Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- A screening program for trisomy 21 at 10–14 weeks using fetal nuchal translucency, maternal serum free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A.Ultrasound Obstet Gynecol. 1999; 13: 231-237
- Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free beta-hCG and pregnancy-associated plasma protein-A.Humanit Rep. 2008; 23: 1968-1975
- Relationship between nuchal translucency thickness and prevalence of major cardiac defects in fetuses with normal karyotype.Ultrasound Obstet Gynecol. 2005; 26: 154-157
- Increased nuchal translucency with normal karyotype.Am J Obstet Gynecol. 2005; 192: 1005-1021
- First-trimester biochemical markers of aneuploidy and the prediction of small-for-gestational age fetuses.Ultrasound Obstet Gynecol. 2008; 31: 15-19
- First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery.Ultrasound Obstet Gynecol. 2008; 31: 147-152
- Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia.Prenat Diagn. 2008; 28: 7-10
- First trimester maternal serum PAPP-A and pre-eclampsia.Ultrasound Obstet Gynecol. 2009; 33: 23-33
- Maternal cardiac function and uterine artery Doppler at 11–14 weeks in the prediction of pre-eclampsia in nulliparous women.BJOG. 2008; 115: 369-376
- Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11–13 weeks of gestation.Ultrasound Obstet Gynecol. 2009; 33: 259-264
- Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11–13 weeks of gestation.Ultrasound Obstet Gynecol. 2009; 33: 512-517
- Tricuspid regurgitation in screening for trisomies 21, 18 and 13 and Turner syndrome at 11+0 to 13+6 weeks of gestation.Ultrasound Obstet Gynecol. 2009; 33: 18-22
- Fetal tricuspid regurgitation at the 11 + 0 to 13 + 6-week scan: association with chromosomal defects and reproducibility of the method.Ultrasound Obstet Gynecol. 2006; 27: 609-612
- Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.Ultrasound Obstet Gynecol. 2006; 27: 151-155
- Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one stop clinic: a review of three years prospective experience.BJOG. 2003; 110: 281-286
- Choroid plexus cyst, intracardiac echogenic focus, hyperechogenic bowel and hydronephrosis in screening for trisomy 21 at 11 + 0 to 13 + 6 weeks.Ultrasound Obstet Gynecol. 2008; 31: 132-135
- Screening for trisomy 21 in twin pregnancies in the first trimester: an update of the impact of chorionicity on maternal serum markers.Prenat Diagn. 2008; 28: 49-52
- First-trimester screening for trisomy 21 in singleton pregnancies achieved by assisted reproduction.Humanit Rep. 2001; 16: 1501-1504
Article info
Identification
Copyright
© 2010 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
